Investors relieved at $572 million verdict in opioid trial; appeal planned

The Associated Press - August 27, 2019 2:29 pm

By The Associated Press

Johnson & Johnson investors exhaled in relief Tuesday, pushing up shares about 3 percent after an Oklahoma judge imposed a $572 million verdict late Monday for its role in the nation’s opioid crisis.

Investors had been holding their breath during a trial in which the state of Oklahoma, calling J&J a “kingpin” in the epidemic, sought up to $17 billion. The much-smaller verdict, and J&J’s immediate response that the verdict was “flawed” and it will appeal, reassured investors, for now.

“The risk of a loss was already baked into the stock price,” and this verdict doesn’t set a precedent for other cases, noted Erik Gordon, an analyst and professor at University of Michigan’s Ross School of Business.

 

Latest Stories

Judge gives control of Joe Exotic’s zoo to Carole Baskin

WYNNEWOOD, Okla. (AP) — A federal judge in Oklahoma has awarded ownership of the zoo made...

Survey shows business leaders optimistic despite coronavirus

OMAHA, Neb. (AP) — A new survey in a nine-state region of the Midwest and Plains...

Pickup drives through Tulsa protesters, several injured

TULSA, Okla. (AP) — Two people were taken to the hospital and several others were injured...